Do diabetes, metabolic syndrome or their association equally affect biventricular function A tissue Doppler study

Hypertension Research

Volumn 36, Issue 1, 2013, Pages 36-42

  Paneni, Francesco ^a   Gregori, Mario ^b   Tocci, Giuliano ^a   Palano, Francesca ^b   Ciavarella, Giuseppino Massimo ^b   Pignatelli, Giulia ^b   Marra, Andrea ^b   Sciarretta, Sebastiano ^a   Ferrucci, Andrea ^b   Volpe, Massimo ^a,b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

biventricular dysfunction; diabetes; heart failure; metabolic syndrome; tissue Doppler imaging

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HEART PERFORMANCE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; WAIST CIRCUMFERENCE;

ADULT; AGED; C-REACTIVE PROTEIN; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84872066410     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.137     Document Type: Article

References (32)

1. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 2004; 27: 1879-1884.
2. Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff Jr DC. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 2004; 27: 699-703.
3. Barac A, Panza J, Howard BV, de Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM. Diabetes and Incident Heart Failure: the Strong Heart Study. High Blood Press Cardiovas Prev 2008; 15: 171-215.
4. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001; 103: 2668-2673.
5. Sciarretta S, Ferrucci A, Ciavarella GM, De Paolis P, Venturelli V, Tocci G, De Biase L, Rubattu S, Volpe M. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome. Am J Hypertens 2007; 20: 784-791.
6. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan DE, Satterfield S, Newman AB, Goodpaster B, Bauer DC, Holvoet P, Harris TB, de Rekeneire N, Rubin S, Ding J, Kritchevsky SBHealth ABC Study. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006; 47: 1595-1602.
7. de Simone G, Devereux RB, Chinali M, Lee ET, Howard B. Interaction of metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular risk: the Strong Heart Study. High Blood Press Cardiovas Prev 2007; 14: 145-196.
8. Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, Szklo M, Lima JA. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J AmColl Cardiol 2008; 51: 1775-1783.
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25: 1751-1762.
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith Jr SC. International diabetes federation task force on epidemiology and prevention. Circulation 2009; 120: 1640-1645.
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
12. de Simone G, Devereux RB, Ganau A, Hahn RT, Saba PS, Mureddu GF, Roman MJ, Howard BV. Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography. Am J Cardiol 1996; 78: 801-807.
13. Paneni F, Gregori M, Ciavarella GM, Sciarretta S, Tocci G, Palano F, Domenici A, Punzo G, De Biase L, Menè P, Volpe M. Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal disease. Int J Cardiol 2011; 149: 250-252.
14. Sciarretta S, Paneni F, Ciavarella GM, De Biase L, Palano F, Baldini R, Quarta G, Tocci G, Benedetto U, Ferrucci A, Rubattu S, de Simone G, Volpe M. Evaluation of systolic properties in hypertensive patients with different degrees of diastolic dysfunction and normal ejection fraction. Am J Hypertens 2009; 22: 437-443.
15. Paneni F, Gregori M, Ciavarella GM, Sciarretta S, De Biase L, Marino L, Tocci G, Principe F, Domenici A, Luciani R, Punzo G, Menè P, Volpe M. Right ventricular dysfunction in patients with end-stage renal disease. Am J Nephrol 2010; 32: 432-438.
16. Paneni F, Gregori M, Ciavarella GM, Sciarretta S, Palano F, Pignatelli G, Castello L, Domenici A, Punzo G, Tocci G, De Biase L, Menè P, Volpe M. Relation between right and left ventricular function in patients undergoing chronic dialysis. J Cardiovasc Med 2011. (e-pub ahead of print 20 December 2011; doi:10. 2459/JCM. 0b013e32834 eacf0).
17. Jenkins C, Chan J, Bricknell K, Strudwick M, Marwick TH. Reproducibility of right ventricular volumes and ejection fraction using real-time threedimensional echocardiography: comparison with cardiac MRI. Chest 2007; 131: 1844-1851.
18. Sade LE, Gülmez O, Ozyer U, Ozgül E, Agildere M, Müderrisoglu H. Tissue Doppler study of the right ventricle with a multisegmental approach: comparison with cardiac magnetic resonance imaging. J Am Soc Echocardiogr 2009; 22: 361-368.
19. Poulsen MK, Henriksen JE, Dahl J, Johansen A, Gerke O, Vach W, Haghfelt T, Høilund-Carlsen PF, Beck-Nielsen H, Møller JE. Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging 2010; 3: 24-31.
20. Ng AC, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Hooi Ewe S, Siebelink HM, Smit JW, Diamant M, Romijn JA, de Roos A, Leung DY, Lamb HJ, Bax JJ. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation 2010; 122: 2538-2544.
21. Fang ZY, Schull-Meade R, Downey M, Prins J, Marwick TH. Determinants of subclinical diabetic heart disease. Diabetologia 2005; 48: 394-402.
22. Gong HP, Tan HW, Fang NN, Song T, Li SH, Zhong M, Zhang W, Zhang Y. Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging. Diabetes Res Clin Pract 2009; 83: 300-307.
23. Voulgari C, Moyssakis i, Papazafiropoulou A, Perrea D, Kyriaki D, Katsilambros N, Tentolouris N. The impact of metabolic syndrome on left ventricular myocardial performance. Diabetes Metab Res Rev 2010; 26: 121-127.
24. Moller J, Poulsen S, Egstrup K. Effect of preload alternations on a new Doppler echocardiographic index of combined systolic and diastolic performance. J Am Soc Echocardiogr 1999; 12: 1065-1072.
25. Paneni F, Gregori M, Pignatelli G, Ciavarella GM, Punzo G, De Biase L, Tocci G, Menè P, Volpe M. Pathophysiology of biventricular dysfunction during hemodialysis: emerging concepts. Int J Cardiol 2012; 155: 478-479.
26. Kim H, Yoon HJ, Park HS, Cho YK, Nam CW, Hur SH, Kim YN, Kim KB. Usefulness of tissue Doppler imaging-myocardial performance index in the evaluation of diastolic dysfunction and heart failure with preserved ejection fraction. Clin Cardiol 2011; 34: 494-499.
27. Mishra RK, Kizer JR, Palmieri V, Roman MJ, Galloway JM, Fabsitz RR, Lee ET, Best LG, Devereux RB. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study. Echocardiography 2007; 24: 340-347.
28. Arnlöv J, Lind L, Andrén B, Risérus U, Berglund L, Lithell HA. Doppler-derived index of combined left ventricular systolic and diastolic function is an independent predictor of cardiovascular mortality in elderly men. Am Heart J 2005; 149: 902-147.
29. Mogelvang R, Sogaard P, Pedersen SA, Olsen NT, Marott JL, Schnohr P, Goetze JP, Jensen JS. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 2009; 119: 2679-2685.
30. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006; 98: 596-605.
31. Volpe M, Cosentino F, Tocci G, Palano F, Paneni F. Antihypertensive therapy in diabetes: the legacy effect and RAAS blockade. Curr Hypertens Rep 2011; 13: 318-324.
32. Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA 2005; 294: 334-341.